- About this Journal ·
- Abstracting and Indexing ·
- Advance Access ·
- Aims and Scope ·
- Annual Issues ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
Journal of Biomedicine and Biotechnology
Volume 2012 (2012), Article ID 601786, 6 pages
Involvement of the Intrarenal Renin-Angiotensin System in Experimental Models of Glomerulonephritis
Department of Pediatrics, Institute of Health Biosciences, The University of Tokushima Graduate School, Kuramoto-cho 3-18-15, Tokushima, Tokushima 770-8503, Japan
Received 9 January 2012; Accepted 9 June 2012
Academic Editor: Oreste Gualillo
Copyright © 2012 Maki Urushihara et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- L. G. Navar, L. M. Harrison-Bernard, J. D. Imig, C. T. Wang, L. Cervenka, and K. D. Mitchell, “Intrarenal angiotensin II generation and renal effects of AT1 receptor blockade,” Journal of the American Society of Nephrology, vol. 10, supplement 12, pp. S266–S272, 1999.
- H. Kobori, M. Nangaku, L. G. Navar, and A. Nishiyama, “The intrarenal renin-angiotensin system: from physiology to the pathobiology of hypertension and kidney disease,” Pharmacological Reviews, vol. 59, no. 3, pp. 251–287, 2007.
- R. M. Carey and H. M. Siragy, “The intrarenal renin-angiotensin system and diabetic nephropathy,” Trends in Endocrinology and Metabolism, vol. 14, no. 6, pp. 274–281, 2003.
- R. A. S. Santos, A. C. Simoes e Silva, C. Maric et al., “Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 14, pp. 8258–8263, 2003.
- L. G. Navar, M. C. Prieto-Carrasquero, and H. Kobori, Chapter 1: Molecular Aspects of the Renal Renin-Angiotensin System, Taylor & Francis Medical, Oxfordshine, UK, 1st edition, 2006.
- V. J. Dzau and R. Re, “Tissue angiotensin system in cardiovascular medicine: a paradigm shift?” Circulation, vol. 89, no. 1, pp. 493–498, 1994.
- O. Baltatu, J. A. Silva Jr., D. Ganten, and M. Bader, “The brain renin-angiotensin system modulates angiotensin II-induced hypertension and cardiac hypertrophy,” Hypertension, vol. 35, no. 1, part 2, pp. 409–412, 2000.
- L. J. Dell'Italia, Q. C. Meng, E. Balcells et al., “Compartmentalization of angiotensin II generation in the dog heart: evidence for independent mechanisms in intravascular and interstitial spaces,” Journal of Clinical Investigation, vol. 100, no. 2, pp. 253–258, 1997.
- G. Mazzocchi, L. K. Malendowicz, A. Markowska, G. Albertin, and G. G. Nussdorfer, “Role of adrenal renin-angiotensin system in the control of aldosterone secretion in sodium-restricted rats,” American Journal of Physiology, vol. 278, no. 6, pp. E1027–E1030, 2000.
- K. K. Griendling, C. A. Minieri, J. D. Ollerenshaw, and R. W. Alexander, “Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells,” Circulation Research, vol. 74, no. 6, pp. 1141–1148, 1994.
- A. H. J. Danser, P. J. J. Admiraal, F. H. M. Derkx, and M. A. D. H. Schalekamp, “Angiotensin I-to-II conversion in the human renal vascular bed,” Journal of Hypertension, vol. 16, no. 12, part 2, pp. 2051–2056, 1998.
- L. G. Navar, L. M. Harrison-Bernard, A. Nishiyama, and H. Kobori, “Regulation of intrarenal angiotensin II in hypertension,” Hypertension, vol. 39, no. 2, part 2, pp. 316–322, 2002.
- A. R. Brasier and J. Li, “Mechanisms for inducible control of angiotensinogen gene transcription,” Hypertension, vol. 27, no. 3, part 2, pp. 465–475, 1996.
- W. L. Henrich, E. A. McAllister, A. Eskue, T. Miller, and O. W. Moe, “Renin regulation in cultured proximal tubular cells,” Hypertension, vol. 27, no. 6, pp. 1337–1340, 1996.
- M. Sibony, J. M. Gasc, F. Soubrier, F. Alhenc-Gelas, and P. Corvol, “Gene expression and tissue localization of the two isoforms of angiotensin I converting enzyme,” Hypertension, vol. 21, no. 6, part 1, pp. 827–835, 1993.
- C. P. Vío and V. A. Jeanneret, “Local induction of angiotensin-converting enzyme in the kidney as a mechanism of progressive renal diseases,” Kidney International, Supplement, vol. 64, no. 86, pp. S57–S63, 2003.
- D. E. Casarini, M. A. Boim, R. C. R. Stella, M. H. Krieger-Azzolini, J. E. Krieger, and N. Schor, “Angiotensin I-converting enzyme activity in tubular fluid along the rat nephron,” American Journal of Physiology, vol. 272, no. 3, part 2, pp. F405–F409, 1997.
- D. E. Kohan, “Angiotensin II and endothelin in chronic glomerulonephritis,” Kidney International, vol. 54, no. 2, pp. 646–647, 1998.
- M. Urushihara and H. Kobori, “Angiotensinogen expression is enhanced in the progression of glomerular disease,” International Journal of Clinical Medicine, vol. 2, no. 4, pp. 378–387, 2011.
- Y. Horita, M. Tadokoro, K. Taura et al., “Low-dose combination therapy with temocapril and losartan reduces proteinuria in normotensive patients with immunoglobulin A nephropathy,” Hypertension Research, vol. 27, no. 12, pp. 963–970, 2004.
- P. Ruggenenti, A. Perna, G. Gherardi, F. Gaspari, R. Benini, and G. Remuzzi, “Renal function and requirement for dialysis in chronic nephropathy patients on long-term ramipril: REIN follow-up trial,” The Lancet, vol. 352, no. 9136, pp. 1252–1256, 1998.
- M. Ishizaki, Y. Masuda, and Y. Fukuda, “Experimental mesangioproliferative glomerulonephritis in rats induced by intravenous administration of anti-thymocyte serum,” Acta Pathologica Japonica, vol. 36, no. 8, pp. 1191–1203, 1986.
- N. Sakai, K. Iseki, S. Suzuki et al., “Uninephrectomy induces progressive glomerulosclerosis and apoptosis in anti-Thy1 glomerulonephritis,” Pathology International, vol. 55, no. 1, pp. 19–26, 2005.
- H. Kawachi, T. Iwanaga, S. Toyabe, T. Oite, and F. Shimizu, “Mesangial sclerotic change with persistent proteinuria in rats after two consecutive injections of monoclonal antibody 1-22-3,” Clinical and Experimental Immunology, vol. 90, no. 1, pp. 129–134, 1992.
- T. Nakamura, J. E. Obata, H. Kimura et al., “Blocking angiotensin II ameliorates proteinuria and glomerular lesions in progressive mesangioproliferative glomerulonephritis,” Kidney International, vol. 55, no. 3, pp. 877–889, 1999.
- S. Kondo, M. Shimizu, M. Urushihara et al., “Addition of the antioxidant probucol to angiotensin II type I receptor antagonist arrests progressive mesangioproliferative glomerulonephritis in the rat,” Journal of the American Society of Nephrology, vol. 17, no. 3, pp. 783–794, 2006.
- S. A. Gaertner, U. Janssen, T. Ostendorf, K. M. Koch, J. Floege, and W. Gwinner, “Glomerular oxidative and antioxidative systems in experimental mesangioproliferative glomerulonephritis,” Journal of the American Society of Nephrology, vol. 13, no. 12, pp. 2930–2937, 2002.
- M. N. Budisavljevic, L. Hodge, K. Barber et al., “Oxidative stress in the pathogenesis of experimental mesangial proliferative glomerulonephritis,” American Journal of Physiology, vol. 285, no. 6, pp. F1138–F1148, 2003.
- Y. Gorin, J. M. Ricono, B. Wagner et al., “Angiotensin II-induced ERK1/ERK2 activation and protein synthesis are redox-dependent in glomerular mesangial cells,” Biochemical Journal, vol. 381, part 1, pp. 231–239, 2004.
- M. Shibanuma, J. I. Mashimo, T. Kuroki, and K. Nose, “Characterization of the TGFβ1-inducible hic-5 gene that encodes a putative novel zinc finger protein and its possible involvement in cellular senescence,” Journal of Biological Chemistry, vol. 269, no. 43, pp. 26767–26774, 1994.
- M. Matsuya, H. Sasaki, H. Aoto et al., “Cell adhesion kinase β forms a complex with a new member, Hic-5, of proteins localized at focal adhesions,” Journal of Biological Chemistry, vol. 273, no. 2, pp. 1003–1014, 1998.
- D. A. Tumbarello and C. E. Turner, “Hic-5 contributes to epithelial-mesenchymal transformation through a RhoA/ROCK-dependent pathway,” Journal of Cellular Physiology, vol. 211, no. 3, pp. 736–747, 2007.
- G. Dabiri, D. A. Tumbarello, C. E. Turner, and L. Van de Water, “Hic-5 promotes the hypertrophic scar myofibroblast phenotype by regulating the TGF-β1 autocrine loop,” Journal of Investigative Dermatology, vol. 128, no. 10, pp. 2518–2525, 2008.
- K. Suga, S. Kondo, S. Matsuura, et al., “Glomerular expression of hydrogen peroxide inducible clone-5 in human and rat progressive mesagnial proliferative glomerulonephritis,” Nephron Experimental Nephrology, vol. 120, no. 2, pp. e59–e68, 2012.
- S. Nishimoto and E. Nishida, “MAPK signalling: ERK5 versus ERK1/2,” EMBO Reports, vol. 7, no. 8, pp. 782–786, 2006.
- D. Bokemeyer, D. Panek, H. J. Kramer et al., “In vivo identification of the mitogen-activated protein kinase cascade as a central pathogenic pathway in experimental mesangioproliferative glomerulonephritis,” Journal of the American Society of Nephrology, vol. 13, no. 6, pp. 1473–1480, 2002.
- T. Masaki, C. Stambe, P. A. Hill, J. Dowling, R. C. Atkins, and D. J. Nikolic-Paterson, “Activation of the extracellular-signal regulated protein kinase pathway in human glomerulopathies,” Journal of the American Society of Nephrology, vol. 15, no. 7, pp. 1835–1843, 2004.
- Y. Suzaki, M. Yoshizumi, S. Kagami et al., “BMK1 is activated in glomeruli of diabetic rats and in mesangial cells by high glucose conditions,” Kidney International, vol. 65, no. 5, pp. 1749–1760, 2004.
- M. Urushihara, M. Takamatsu, M. Shimizu, et al., “ERK5 activation enhances mesangial cell viability and collagen matrix accumulation in rat progressive glomerulonephritis,” American Journal of Physiology Renal Physiology, vol. 298, no. 1, pp. F167–F176, 2009.
- H. Okada, T. Inoue, T. Kikuta et al., “A possible anti-inflammatory role of angiotensin II type 2 receptor in immune-mediated glomerulonephritis during type 1 receptor blockade,” American Journal of Pathology, vol. 169, no. 5, pp. 1577–1589, 2006.
- N. Ohashi, M. Urushihara, R. Satou, and H. Kobori, “Glomerular angiotensinogen is induced in mesangial cells in diabetic rats via reactive oxygen speciesERK/JNK pathways,” Hypertension Research, vol. 33, no. 11, pp. 1174–1181, 2010.
- A. P. Lakshmanan, R. A. Thandavarayan, K. Watanabe, et al., “Modulation of AT-1R/MAPK cascade by an olmesartan treatment attenuates diabetic nephropathy in streptozotocin-induced diabetic mice,” Molecular and cellular endocrinology, vol. 348, no. 1, pp. 104–111, 2012.
- H. Ha and Hi Bahl Lee, “Reactive oxygen species as glucose signaling molecules in mesangial cells cultured under high glucose,” Kidney International, Supplement, vol. 58, no. 77, pp. S19–S25, 2000.
- D. R. Tomlinson, “Mitogen-activated protein kinases as glucose transducers for diabetic complications,” Diabetologia, vol. 42, no. 11, pp. 1271–1281, 1999.
- E. Tsiani, P. Lekas, I. G. Fantus, et al., “High glucose-enhanced activation of mesangial cell p38 MAPK by ET-1, ANG II, and platelet-derived growth factor,” American Journal of Physiology, vol. 282, no. 1, pp. E161–E169, 2002.
- B. G. Hudson, K. Tryggvason, M. Sundaramoorthy, and E. G. Neilson, “Alport's syndrome, Goodpasture's syndrome, and type IV collagen,” The New England Journal of Medicine, vol. 348, no. 25, pp. 2543–2556, 2003.
- M. Shimizu, S. Kondo, M. Urushihara et al., “Role of integrin-linked kinase in epithelial-mesenchymal transition in crescent formation of experimental glomerulonephritis,” Nephrology Dialysis Transplantation, vol. 21, no. 9, pp. 2380–2390, 2006.
- T. Wada, H. Yokoyama, K. Furuichi et al., “Intervention of crescentic glomerulonephritis by antibodies to monocyte chemotactic and activating factor (MCAF/MCP-1),” The FASEB Journal, vol. 10, no. 12, pp. 1418–1425, 1996.
- Y. Kinoshita, S. Kondo, M. Urushihara, et al., “Angiotensin II type I receptor blockade suppresses glomerular renin-angiotensin system activation, oxidative stress, and progressive glomerular injury in rat anti-glomerular basement membrane glomerulonephritis,” Translational Research, vol. 158, no. 4, pp. 235–248, 2011.
- T. Wada, K. Furuichi, N. Sakai et al., “A new anti-inflammatory compound, FR167653, ameliorates crescentic glomerulonephritis in Wistar-Kyoto rats,” Journal of the American Society of Nephrology, vol. 11, no. 8, pp. 1534–1541, 2000.
- K. Matsushima, C. G. Larsen, G. C. DuBois, and J. J. Oppenheim, “Purification and characterization of a novel monocyte chemotactic and activating factor produced by a human myelomonocytic cell line,” Journal of Experimental Medicine, vol. 169, no. 4, pp. 1485–1490, 1989.
- Y. Ozawa, H. Kobori, Y. Suzaki, and L. G. Navar, “Sustained renal interstitial macrophage infiltration following chronic angiotensin II infusions,” The American Journal of Physiology, vol. 292, no. 1, pp. F330–F339, 2007.
- S. Segerer, Y. Cui, K. L. Hudkins et al., “Expression of the chemokine monocyte chemoattractant protein-1 and its receptor chemokine receptor 2 in human crescentic glomerulonephritis,” Journal of the American Society of Nephrology, vol. 11, no. 12, pp. 2231–2242, 2000.
- M. Urushihara, N. Ohashi, K. Miyata, R. Satou, O. W. Acres, and H. Kobori, “Addition of angiotensin II Type 1 receptor blocker to CCR2 antagonist markedly attenuates crescentic glomerulonephritis,” Hypertension, vol. 57, no. 3, pp. 586–593, 2011.
- T. Wada, K. Matsushima, and K. I. Kobayashi, “Monocyte chemoattractant protein-1: does it play a role in diabetic nephropathy?” Nephrology Dialysis Transplantation, vol. 18, no. 3, pp. 457–459, 2003.
- S. Kato, V. A. Luyckx, M. Ots et al., “Renin-angiotensin blockade lowers MCP-1 expression in diabetic rats,” Kidney International, vol. 56, no. 3, pp. 1037–1048, 1999.
- C. Zoja, D. Corna, D. Rottoli et al., “Effect of combining ACE inhibitor and statin in severe experimental nephropathy,” Kidney International, vol. 61, no. 5, pp. 1635–1645, 2002.
- Y. M. Chen, M. I. Hu-Tsai, S. L. Lin, T. J. Tsai, and B. S. Hsieh, “Expression of CX3CL1/fractalkine by mesangial cells in vitro and in acute anti-Thy1 glomerulonephritis in rats,” Nephrology Dialysis Transplantation, vol. 18, no. 12, pp. 2505–2514, 2003.